Time To Go Long Brainstorm Cell Therapeutics? By: TalkMarkets January 18, 2017 at 10:52 AM EST The similarities in strategy and data between Brainstorm, Bluebird and Sarepta are striking. The discrepancies in valuation present an opportunity. Read More >> Related Stocks: Bluebird Bio Brainstorm Cell Sarepta Therapeutics
